Key Segments:
By Service Type
-
Contract Manufacturing
-
Contract Development
-
Packaging, Labelling & Sterilization
-
Regulatory Affairs
-
Others
By Class
-
Class I
-
Class II
-
Class III
By Application
-
Infectious Disease Diagnostics
-
Oncology Diagnostics
-
Cardiometabolic Diagnostics
-
Genetic & Genomic Testing
-
Respiratory & Critical Care Diagnostics
-
Others
By End Use
-
Original Equipment Manufacturers (OEMs)
-
Pharmaceutical & Biopharmaceutical Companies
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Jabil, Thermo Fisher Scientific, Integer Holdings, Flex, Sanmina, Celestica, Phillips-Medisize, Plexus, Nipro, and Viant.
Key opportunities include companion and precision diagnostics, connected and AI-enabled devices, end-to-end development services, and regional manufacturing expansion.
The market is driven by growing outsourcing of diagnostic device development and manufacturing, rising IVD and point-of-care demand, device complexity, and regulatory requirements.
The Contract Manufacturing segment dominated the Diagnostics Device CDMO Market, accounting for approximately 48% market share.
The North America region dominated the Diagnostics Device CDMO Market in 2025 with approximately 47.2% share, driven by a large diagnostics OEM base, strong investment, and leading CDMO presence.